• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Incyte Corporation (INCY)

    -NasdaqGS
    107.34 Down 0.51(0.47%) Apr 24, 4:00PM EDT
    |After Hours : 107.50 Up 0.16 (0.15%) Apr 24, 5:26PM EDT
    Add to Portfolio
    Prev Close:107.85
    Open:107.59
    Bid:107.34 x 100
    Ask:114.87 x 100
    1y Target Est:98.08
    Beta:0.08
    Next Earnings Date:30-Apr-15INCY Earnings announcement
    Day's Range:106.75 - 108.55
    52wk Range:43.44 - 111.93
    Volume:854,645
    Avg Vol (3m):1,194,710
    Market Cap:18.61B
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 0.47%18.61B
    AMGNDown 0.74%127.61B
    CELGUp 2.26%95.04B
    RHHBYDown 0.83%N/A

    Key Statistics

    Forward P/E (1 yr):109.53
    P/S (ttm):36.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (Mar-15) :-0.09
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-5.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback